Related Experiment Video

Updated: Mar 3, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K

Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency

Hasan M Isa1, Masooma S Mohamed2, Afaf M Mohamed3

  • 1Pediatric Department, Arabian Gulf University, Manama, Bahrain.

Korean Journal of Pediatrics
|May 3, 2017
PubMed

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a significant risk factor for severe neonatal indirect hyperbilirubinemia (NIH). Prompt management in G6PD-deficient neonates is crucial to prevent neurological damage.

Area of Science:

  • Pediatrics
  • Neonatology
  • Medical Genetics

Background:

  • Neonatal indirect hyperbilirubinemia (NIH) is a common condition in newborns.
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder affecting red blood cells.
  • The association between G6PD deficiency and severe NIH requires further investigation.

Purpose of the Study:

  • Determine the prevalence of G6PD deficiency in infants with NIH.
  • Compare NIH patients with and without G6PD deficiency regarding hyperbilirubinemia severity and need for exchange transfusion (ET).
  • Identify risk factors for ET and kernicterus in NIH patients.

Main Methods:

  • Retrospective case-control study of 1,129 NIH infants admitted between 2007 and 2010.
  • Collected data included demographics, clinical parameters, laboratory results, and G6PD status.
  • Compared outcomes between G6PD-deficient and G6PD-normal patient groups.

Main Results:

  • G6PD deficiency was found in 42% of tested NIH infants, predominantly males.
  • G6PD-deficient infants exhibited lower hemoglobin, higher bilirubin levels, and a greater need for ET.
  • Significant risk factors for ET included G6PD deficiency, low hemoglobin, and high bilirubin levels.

Conclusions:

  • G6PD deficiency is a critical risk factor for severe NIH.
  • Early and aggressive management of NIH in G6PD-deficient neonates is essential.
  • Prompt intervention can prevent irreversible neurological complications like kernicterus.
Abstract

Keywords:
Glucosephosphate dehydrogenase deficiencyKernicterusNeonatal hyperbilirubinemiaWhole blood exchange transfusion

More Related Videos

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina07:04

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Published on: March 14, 2025

829
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.6K

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
962
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.8K